We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
GTA-ONDANSETRON, PTIN-ONDANSETRON, Ipca-ONDANSETRON, ONDANSETRON APOTEX, TN-ONDANSETRON, PIP-ONDANSETRON (Apotex Pty Ltd)
Product name
GTA-ONDANSETRON, PTIN-ONDANSETRON, Ipca-ONDANSETRON, ONDANSETRON APOTEX, TN-ONDANSETRON, PIP-ONDANSETRON
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
151 working days (255)
Active ingredients
ondansetron hydrochloride dihydrate
Registration type
New generic medicine
Indication
GTA-ONDANSETRON, PTIN-ONDANSETRON, Ipca-ONDANSETRON, ONDANSETRON APOTEX, TN-ONDANSETRON, PIP-ONDANSETRON (tablets) are indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.